The mechanisms of progesterone on endothelial cell motility are poorly investigated. Previously 
Introduction
The endothelium plays a primary role in the regulation of vascular structure and functions. Endothelial dysfunction is a well-established response to cardiovascular risk factors and can be a promoter of atherosclerosis [1, 2] . Menopause is associated with endothelial dysfunction because of sex steroids reduction. In this regard, the impaired flow-mediated dilatation, reduced nitric oxide availability and abnormal endothelial morphology are found in post-menopausal women [3] [4] [5] . These functional abnormities may explain the increased incidence of cardiovascular disease in post-menopausal women. [6] [7] [8] [9] [10] . This apparent discrepancy is still under investigation. Recent years a 'healthy endothelium' concept has been proposed, suggesting that the cardiovascular effects of HRT may largely depend on intact endothelial function [11] . In this regard, the Cardiovascular Health Study demonstrated that favourable vascular effects of HRT are only limited to patients without extensive atherosclerosis [3] . In parallel, our previous work indicated that HRT improves the vascular function and preserves the morphological integrity of endothelial cells in relatively young post-menopausal women [12] .
Hormone replacement therapy (HRT) is believed to induce cardiovascular protection. However, clinical trials have challenged this assumption, reporting no cardiovascular benefit or even increased risk in post-menopausal women receiving HRT
Endothelial cells are primary targets of sex steroids. It is well recognized that oestrogen improves endothelial function through genomic and non-genomic mechanisms [13] . By contrast, less is known on the progesterone's endothelial actions. We recently 297 discovered that progesterone stimulates endothelial migration [14] . By promoting dynamic actin remodelling, progesterone activates the actin-regulatory protein moesin, which supports the formation of membrane filopodia and pseudopodia [14] . These structures are essential for cell migration by interaction with the extracellular matrix via anchorage proteins and focal adhesions (FAs) [15] . FAK activity is essential not only for tumour metastasis [16] , but also for developmental processes controlling blood vessel formation [17] .
Recently we found that progesterone modulates FAK activity in breast cancer cells [18] . 
Materials and methods

Cell cultures and treatments
Human umbilical vein endothelial cells (HUVEC) were cultured as previously described [19] . Before treatments, HUVEC were kept 48 
Cell migration assays
Cell migration was assayed with razor scrape assays as previously described [19] . Briefly, a razor blade was pressed through the confluent HUVEC monolayer into the plastic plate to mark the starting line. HUVEC were swept away on one side of that line. Cells were washed, and 2.0 ml of DMEM containing steroid-deprived FBS and gelatine (1 mg/ml) were added. Cytosine ␤-D-arabinofuranoside hydrochloride (Ara-C, Sigma) (10 M), a selective inhibitor of DNA synthesis, which does not inhibit RNA synthesis was used 1 hr before the test substance was added. Ara-C is easy to enter into the cellular nucleus and it incorporates into DNA and inhibits DNA replication by the formation of cleavage complexes with topoisomerase I resulting in DNA fragmentation. Although the half-life of Ara-C was less than 1 hr in most of the cell lines, more than 80% of Ara-C DNA was retained at 24 hrs after drug removal [20] . Migration was monitored for 48 hrs. Fresh medium and treatment were replaced every 12 hrs. Cells were digitally imaged and migration distance was measured by using phase-contrast microscopy. (Fig. 2B) .
Statistical analysis
PR interacts with the tyrosine kinase c-Src [24] and this process is involved in the activation of PI3K [25] . In line with this, progesterone (10 Ϫ8 mol/l) induced rapid phosphorylation of c-Src at the Tyr 416 in the activation loop of the kinase domain, which corresponds to its activation [26] (Fig. 2C) . Likewise, the PI3K downstream effector, protein kinase Akt, was also phosphorylated in response to progesterone (Fig. 2C) . Moreover, the PI3K inhibitor WM had no effect on c-Src activation, whereas the c-Src inhibitor PP2 blocked Akt phosphorylation (Fig. 2C) (Fig. 2E) . The p85 subunit were overexpressed in both WT p85␣ and ⌬p85␣ plasmid transfection group (Fig. 2E) [27, 28] . Recently we have shown that progesterone enhanced RhoA/ROCK-2 activities in breast cancer cells [18] . Similarly, treatment of HUVEC with progesterone increased the amount of active, GTP-bound RhoA (Fig. 3A) (Fig. 3B) . (Fig. 3A, B) . In line with this, RhoA activation was impaired by transfection with ⌬p85␣, whereas transfection with WT p85␣ increased RhoA activation in the presence or absence of progesterone (Fig. 3C) . (Fig. 2B) were transfected with a RhoA constitutively-active construct (RhoA G14V), FAK phosphorylation was ligand-independently enhanced (Fig. 3D) . On the contrary, transfection of a dominant-negative RhoA construct (RhoA T19N) resulted in a significant reduction of progesterone-induced FAK phosphorylation (Fig. 3D ).
versus P. (C) HUVECs were exposed to P (10 nM) for 15 min., in the presence or absence of the ORG 31710 (ORG-1 M), of the PP2 (10 M), of the WM (30 nM), and of the Y-27632 (Y-10 M). P-c-Src and P-Akt densitometry values were adjusted to actin intensity, then normalized to expression
Progesterone was unable to activate Akt when c-Src expression was silenced with specific siRNA (Fig. 2D). In addition, transfection with a dominant-negative form of the regulatory subunit of PI3K, p85␣ (⌬p85␣), resulted in the impairment of FAK activation, whereas the transfection of a wild-type p85␣ construct (WT p85␣) showed an additive effect with progesterone
, implying an efficient transfection in our experimental settings. Taken together, these results suggest that the c-Src/PI3K/Akt cascade is implicated in the PR-dependent FAK activation.
Progesterone-induced FAK activation: role of RhoA/ROCK-2
The small GTPase RhoA and its downstream effector ROCK-2 function as the modulators of actin cytoskeleton by linking upstream signalling events to actin-binding proteins such as moesin or FAK
and of functionally activated ROCK-2, shown by enhanced Thr-phosphorylation of the bait protein MBP by ROCK-2 immunoprecipitates (IPs)
The activation of RhoA/ROCK-2 is mediated by c-Src and PI3K, because inhibitors of both kinases blocked their activation induced by progesterone
Y27632, the inhibitor of ROCK-2, was shown to largely impair progesterone-induced FAK activation
FAK activation is critical for HUVEC migration
Finally the role of FAK activation in endothelial cell migration was interrogated. Consistent with our previous work [14] , progesterone markedly enhanced horizontal migration ( 
Discussion
Female sex hormones have vascular benefits and this is largely attributed to their direct actions on vascular endothelial cells. It is well documented that oestrogen is the potent agent to maintain endothelial morphology and functions [13]. However, little is known about the progesterone's effects on endothelial cells. The major finding of this proposal is the identification of endothelial FAK as the target of progesterone that promotes endothelial cell migration.
Endothelial migration is critical for the physiological or pathophysiological processes such as vessel repair, angiogenesis and wound repair. Cell migration is a highly integrated process implemented by actin reorganization. Our previous studies showed that progesterone induces dynamic actin remodelling and the formation of membrane filopodia and pseudopodia, which are primary steps for endothelial cell migration [14] . This event is linked to the rapid activation by PRs of actin-binding protein moesin, which belongs to the ezrin/radixin/moesin family [29] 
. Protruded membranes then contact the substrate and form novel integrin-dependent FAs, which provides the platform for cells to generate the locomotive force [30]. Besides its ability to provoke actin cytoskeleton remodelling, progesterone is also revealed to increase the formation of FAs, indicating that progesterone may impact on endothelial migration through the modulation of multiple migratory steps.
We [19, 28, 41] . Although the present study displays a tight relationship between FAK activation and endothelial cell motility, the overall contribution of this rapid action to the long-term migration remains to be clarified. Indeed, progesterone may also alter FAK activity through conventional nuclear actions [42] . For [50, 54] . Intriguingly, active FAK is able to interact with p85 to increase its activity, thus creating a positive feedback loop [55] . Therefore [56] . In non-human primates MPA has been shown to interfere with the atheroprotective effects of oestrogens, which does not happen with natural progesterone [57, 58] 
